載入...
Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
Adeno-associated virus (AAV) vectors have been successfully used in patients with bleeding disorders and blindness. For human liver targeting, two major factors restrict effective AAV transduction after systemic administration of AAV vectors: human hepatocyte tropism and neutralizing antibodies (Nab...
Na minha lista:
| 發表在: | Mol Ther Methods Clin Dev |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Gene & Cell Therapy
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7329936/ https://ncbi.nlm.nih.gov/pubmed/32637455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2020.06.003 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|